Description

Primobolan 100 mg (Methenolone Enanthate) — Swiss Remedies

Brand: Swiss Remedies
Category: Injectable AAS · DHT-derived anabolic agent
Content: 100 mg/ml methenolone enanthate
Packing: 10 × 1 ml ampoules (100 mg per ampoule)
Origin: Switzerland
Price: €69
Use: Laboratory research and analytical reference only — not for human or veterinary use.

🧪 Product Overview

Methenolone enanthate (Primobolan) is a long-acting injectable anabolic-androgenic steroid derived from DHT.
Because it cannot aromatise to estrogen and has a relatively mild androgenic profile, it is widely used in research exploring muscle preservation, nitrogen balance, anti-catabolic dynamics, androgen-receptor activation, and biomarker changes under caloric deficit.

In modern laboratory environments, Primobolan serves as a reference standard for detecting methenolone metabolites, evaluating exposure kinetics, and modelling anabolic effects with reduced estrogenic influence.

Methenolone and its esters are listed on the WADA S1 Prohibited List.

🔬 Key Research Highlights

• DHT-derived structure: Non-aromatising backbone ideal for models requiring anabolic signalling without estrogen conversion.
• Long-acting ester: Enanthate ester extends half-life (~10.5 days) and stabilises release in IM depot models.
• Anti-catabolic potential: Explored for lean mass preservation during negative-calorie or muscle-wasting phases.
• Androgen-receptor specificity: Strong AR affinity with mild androgenic signature.
• Anti-doping relevance: Common analyte in AAS detection; metabolite profiling is an area of active research.

🧬 Mechanism of Action

• Androgen receptor activation: Methenolone binds AR in muscle and other tissues, enhancing transcription of anabolic genes.
• Positive nitrogen balance: Supports protein synthesis and prevents catabolism under stress conditions.
• Non-estrogenic: No aromatisation protects against estrogen-related confounders in research models.
• Extended kinetics: Enanthate ester provides slower release and longer detection window than short esters.

📚 Potential Research Applications

• Lean-mass retention studies during caloric deficit or immobilisation.
• Anti-catabolic pathways and muscle-wasting models.
• AR-binding and downstream signalling comparisons with other DHT derivatives.
• Lipid panel and cardiovascular markers under AAS exposure.
• Anti-doping metabolite detection and identification of long-term biomarkers.

⚠️ Side Effects & Risk Indicators (Class-Based)

• Endocrine suppression: Reduced LH, FSH, and endogenous testosterone; possible temporary infertility.
• Androgenic effects: Acne, oily skin, androgenic alopecia; virilisation risks in females.
• Cardiometabolic risks: Reduced HDL, increased LDL, potential blood-pressure elevation.
• Liver markers: Lower hepatotoxicity than oral DHT analogues, but elevated enzymes possible with prolonged use.
• Psychological changes: Irritability, mood fluctuation, or behavioural changes — class dependent.

🧯 Compliance & Anti-Doping Status

Methenolone (Primobolan) is prohibited at all times by the World Anti-Doping Agency (WADA), Section S1 – Anabolic Agents.
It is a controlled substance in many jurisdictions and often requires prescription authorisation.

This product is supplied strictly for research, forensic, and analytical purposes.
It is not a dietary supplement, not a performance enhancer for human use, and not intended for bodybuilding cycles.

📊 Technical Specifications